115 related articles for article (PubMed ID: 24495349)
21. Spinal cord ependymoma: a review of the literature and case series of ten patients.
Celano E; Salehani A; Malcolm JG; Reinertsen E; Hadjipanayis CG
J Neurooncol; 2016 Jul; 128(3):377-86. PubMed ID: 27154165
[TBL] [Abstract][Full Text] [Related]
22. Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.
Hagel C; Stemmer-Rachamimov AO; Bornemann A; Schuhmann M; Nagel C; Huson S; Evans DG; Plotkin S; Matthies C; Kluwe L; Mautner VF
Neuropathology; 2012 Dec; 32(6):611-6. PubMed ID: 22394059
[TBL] [Abstract][Full Text] [Related]
23. Intramedullary clear cell ependymoma in the cervical spinal cord: case report.
Akutsu H; Shibata Y; Okazaki M; Hyodo A; Matsumura A
Neurosurgery; 2000 Dec; 47(6):1434-7; discussion 1437-8. PubMed ID: 11126915
[TBL] [Abstract][Full Text] [Related]
24. Unusual paediatric spinal myxopapillary ependymomas: Unique molecular entities or pathological variations on a theme?
Rogers S; Jones DTW; Ireland A; Gottardo NG; Endersby R
J Clin Neurosci; 2018 Apr; 50():144-148. PubMed ID: 29402569
[TBL] [Abstract][Full Text] [Related]
25. MYCN amplification in spinal ependymoma: A five-year retrospective study.
Rao S; Sugur H; Konar S; Arivazhagan A; Santosh V
Neuropathology; 2023 Dec; 43(6):457-462. PubMed ID: 37221449
[TBL] [Abstract][Full Text] [Related]
26. Association of lower cranial nerve schwannoma with spinal ependymoma in ? NF2.
Kumar R; Sharma KH; Chhabra DK
Neurol India; 1999 Jun; 47(2):145-7. PubMed ID: 10447465
[TBL] [Abstract][Full Text] [Related]
27. Giant spinal cord ependymoma with CSF spread.
Su X; Huang QF; Shi W; Chen JG; Chen J
Neurology; 2012 Sep; 79(13):1409. PubMed ID: 23008221
[No Abstract] [Full Text] [Related]
28. Spinal tanycytic ependymomas.
Kawano N; Yagishita S; Oka H; Utsuki S; Kobayashi I; Suzuki S; Tachibana S; Fujii K
Acta Neuropathol; 2001 Jan; 101(1):43-8. PubMed ID: 11194940
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype.
Kresbach C; Dorostkar MM; Suwala AK; Wefers AK; Schweizer L; Engertsberger L; Bison B; Mynarek M; Kloth-Stachnau K; Spohn M; von Deimling A; Benesch M; Hagel C; Mautner VF; Rutkowski S; Schüller U
Acta Neuropathol; 2021 Jun; 141(6):971-974. PubMed ID: 33844070
[No Abstract] [Full Text] [Related]
30. Giant Cell-rich Tanycytic Ependymoma as Intramedullary Spinal Mass.
Parkhi M; Gupta K; Singh A; Salunke P
Neurol India; 2019; 67(5):1327-1330. PubMed ID: 31744969
[TBL] [Abstract][Full Text] [Related]
31. [Ependymoma that conditions extended cervical/thoracic/lumbar syringomyelia. A case report and review of the literature].
Méndez-Castillo JJ; García-Angelo R; Zermeño-Pohls F
Rev Neurol; 2003 Jan 16-31; 36(2):198-9. PubMed ID: 12589611
[No Abstract] [Full Text] [Related]
32. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.
Raffeld M; Abdullaev Z; Pack SD; Xi L; Nagaraj S; Briceno N; Vera E; Pittaluga S; Lopes Abath Neto O; Quezado M; Aldape K; Armstrong TS; Gilbert MR
Acta Neuropathol Commun; 2020 Jul; 8(1):101. PubMed ID: 32641156
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas.
Schüller U; Gocke A; Godbole S; Delbridge C; Thomas C; Neumann JE
Acta Neuropathol; 2024 May; 147(1):83. PubMed ID: 38735021
[No Abstract] [Full Text] [Related]
34. Intramedullary ependymoma associated with Lhermitte-Duclos disease and Cowden syndrome.
Farhadi MR; Rittierodt M; Stan A; Capelle HH; Tham-Mücke B; Krauss JK
Clin Neurol Neurosurg; 2007 Oct; 109(8):692-7. PubMed ID: 17544575
[TBL] [Abstract][Full Text] [Related]
35. Papillary ependymoma of the cervical spinal cord.
Vaquero J; Martinez R; el-Barkani A; Aragonés P
Neurosurgery; 1989 Jan; 24(1):140-1. PubMed ID: 2927592
[No Abstract] [Full Text] [Related]
36. Intramedullary subependymoma with neurofibromatosis--report of two cases.
Nakasu S; Nakasu Y; Saito A; Handa J
Neurol Med Chir (Tokyo); 1992 May; 32(5):275-80. PubMed ID: 1378943
[TBL] [Abstract][Full Text] [Related]
37. A reply.
Curtis J; Lewis-Jones H
Clin Radiol; 2000 Dec; 55(12):986. PubMed ID: 11194827
[No Abstract] [Full Text] [Related]
38. Unilateral, multilevel, interlaminar fenestration in the removal of a multisegment cervical intramedullary ependymoma.
Xie T; Qian J; Wu X; Lu Y; Hu G; Luo C
Spine J; 2013 Jul; 13(7):747-53. PubMed ID: 23541449
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis.
Roos KL; Muckway M
Dermatol Clin; 1995 Jan; 13(1):105-11. PubMed ID: 7712636
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: Systematic review and case.
Snyder MH; Ampie L; DiDomenico JD; Asthagiri AR
J Clin Neurosci; 2021 Apr; 86():79-84. PubMed ID: 33775351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
